References
- Alpert, N.R., Mulieri, L.A., Warshaw, D. The failing human heart. Cardiovascular Research. 54, 1-10, 2002 https://doi.org/10.1016/S0008-6363(02)00248-1
- Francis, G.S. Pathophysiology of chronic heart failure. American Journal of Medicine. 110, 37-46, 2001 https://doi.org/10.1016/S0002-9343(98)00385-4
- Braunwald, E., Bristow, M.R. Congestive heart failure: fifty years of progress. Circulation 102, 14-23, 2000 https://doi.org/10.1161/01.CIR.102.1.14
- Katzung, B.G., Parmley, W.W. Cardiac Glycosides & Other Drugs Used in Congestive Heart Failure. 8th Ed., New York, McGraw Hill, 200-218, 2001
- Felker, G.M., O'Connor, C.M. Inotropic therapy for heart failure: an evidence-based approach. American Heart Journal 142, 393-401, 2001 https://doi.org/10.1067/mhj.2001.117606
- Konstam, M.A., Mann, D.L. Contemporary medical options for treating patients with heart failure. Circulation 105, 2244-2246, 2002 https://doi.org/10.1161/01.CIR.0000017420.85607.2D
- Lehmann, H.D. Effect of plant glycosides on resistance and capacitance vessels. Arzneimittel-Forschung-Drug Research 34(4):423-429, 1984
- Lonn, E., Mckelvie, R. Drug treatment in heart failure. British Medical Journal 320, 1188-1192, 2000 https://doi.org/10.1136/bmj.320.7243.1188
- Cho, K.W., Kim, S.H., Kim, C.H., Seul, K.H. Mechanical basis of ANP secretion in beating atria: atrial stroke volume and ECF translocation. American Journal of Physiology 268, 1129-1136, 1995
- Guyton, A.C., Hall, J.E. Textbook of medical physiology. 9th Ed., Saunders, Pennsylvania, 107-119, 1996
- Hasenfuss, G., Pieske, B. Calcium cycling in congestive heart failure. Journal of Molecular and Cellular Cardiology 34, 951-969, 2002 https://doi.org/10.1006/jmcc.2002.2037
- Smith, T.W., Artman, E.M., Friedman, P.L., Blatt, C.M., Marsch, J.D. Digitalis glycosides: mechanism and manifestation of toxicity. Progress in Cardiovascular Diseases 26, 495-540, 1984 https://doi.org/10.1016/0033-0620(84)90014-8
-
Reuter, H., Henderson, S.A., Han, T., Ross, R.S., Goldhaber, J.I., Philipson, K.D. The
$Na^+-Ca2^+$ exchanger is essential for the action of cardiac glycosides. Journal of Cardiovascular Electrophysiology 12, 1295-1301, 2001 https://doi.org/10.1046/j.1540-8167.2001.01295.x - Leier, C.V., Binkley, P.F. Parenteral inotropic support for advanced congestive heart failure. Progress in Cardiovascular Diseases 41(3):207-224, 1998 https://doi.org/10.1016/S0033-0620(98)80056-X
- Katz, A. Potential deleterious effect of inotropic agents in the therapy of chronic heart failure. Circulation 73, 184-190, 1986
- Simaan, J.A., Faswaz, G., Jabbour, K. Comparison of the cardiodynamic and metabolic effects of dobutamine with those of norepinephrine and dopamine in the isolated heart. Naunyn-Schmiedeberg's Arch Pharmacal 338, 174-179, 1988
- Tang, W., Eisenbrand, G. Chinese crugs of plant origine: chemistry, pharmacology, and used in traditional and modern medicine. Springer-Verlag, Berlin, Germany, pp 361-371, 1992
- Schmeller, T., Latz-Bruning, B., Wink, M. Biochemical activities of berberine, palmatine and sanguinarine mediating chemical defence against microorganisms and herbivores. Phytochemistry 44, 257-266, 1997 https://doi.org/10.1016/S0031-9422(96)00545-6
- Nishino, H., Kitagawa, K., Fujiki, H., Iwashima, A. Berberine sulfate inhibits tumor-promoting activity of teleocidin in two-stage carcinogenesis on mouse skin. Oncology 43(2):131-134, 1986 https://doi.org/10.1159/000226349
- Lau, C.W., Yao, X.Q., Chen, Z.Y., Ko, W.H., Huang, Y. Cardiovascular action of berberine. Cardiovascular Drug Review 19, 234-244, 2001
- Sack, R.B., Froehlich, J.L. Berberine inhibits intestinal secretory response of Vibrio chlerae and Escherichia coli enterotoxins. Infection and Immunity 35, 471-475, 1982
- Zeng, X., Zeng, X. Relationship between the clinical effects of berberine on severe congestive heart failure and its concentration in plasma studied by HPLC. Biomedical Chromatography 13(7):442-444, 1999 https://doi.org/10.1002/(SICI)1099-0801(199911)13:7<442::AID-BMC908>3.0.CO;2-A
- Ko, W.H., Yao, X.O., Lau, C.W., Law, W.I., Chen, Z.Y., Kwok, W., Ho, K., Huang, Y. Vasorelaxant and antiproliferative effect of berberine. European Journal of Pharmacology 399, 187-196, 2000 https://doi.org/10.1016/S0014-2999(00)00339-3
- Chun, Y.T., Yip, T.T., Lau, K.L., Kong, Y.C., Sankawa, U. A biochemical study on the hypotensive effect of berberine in rats. General Pharmacology 10(3), 177-182, 1979 https://doi.org/10.1016/0306-3623(79)90085-5
- Kang, D.G., Sohn, E.J., Kwon, E.K., Han, J.H., Oh, H., Lee, H.S. Effects of berberine on angiotensin-converting enzyme and NO/cGMP system in vessels. Vascular Pharmacology 39(6):281-286, 2002 https://doi.org/10.1016/S1537-1891(03)00005-3
- Kimura, M., Thoma, M., Kikuchi, T. The constituents of Convallaria. II. The isolation of desglucocheirotoxin. Japanese Journal of Pharmacology 82, 1320-1323, 1962
- Kimura, M., Thoma, M., Yoshizawa, I. The constituents of Convallaria. II. The isolation of convallasaponin-A, -B, -C. Chemical & Pharmaceutical Bulletin 14(1):50-55, 1966 https://doi.org/10.1248/cpb.14.50
- Kimura, M., Thoma, M., Yoshizawa, I. The constituents of Convallaria. VII. Structure of convallagenin-A. Chemical & Pharmaceutical Bulletin 15(8):1204-1211, 1967 https://doi.org/10.1248/cpb.15.1204
- Wolfgang, K., Brigitte, K., Kurt, J., Helmut, R. Zur biogenese von strophanthidin-glycosiden: Convallatoxol als vorstufe von convallatoxin in Convallaria majalis. Phytochemistry 13, 1805-1808, 1974 https://doi.org/10.1016/0031-9422(74)85094-6
-
Ozaki, H., Nagase, H., Urakawa, N. Interaction of palytoxin and cardiac glycosides on erythrocyte membranes and
$Na^+-K^+$ ATPase. European Journal of Biochemistry 152, 475-480, 1985 https://doi.org/10.1111/j.1432-1033.1985.tb09221.x